|
BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A |
Shaw L, Rodgers H, Price C, van Wijck F, Shackley P, Steen N, Barnes M, Ford G, Graham L |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Shaw L, Rodgers H, Price C, van Wijck F, Shackley P, Steen N, Barnes M, Ford G, Graham L. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A. Health Technology Assessment 2010; 14(25): 1-142 Indexing Status Subject indexing assigned by NLM MeSH Activities of Daily Living; Adaptation, Psychological; Aged; Botulinum Toxins, Type A /economics /therapeutic use; Cognition; Confidence Intervals; Cost-Benefit Analysis; Female; Great Britain; Health Status Indicators; Humans; Male; Middle Aged; Muscle Spasticity /drug therapy /economics /etiology /psychology; Neuromuscular Agents /economics /therapeutic use; Pain Measurement; Parasympatholytics /therapeutic use; Psychometrics; Quality of Life; Quality-Adjusted Life Years; Risk; Stroke /complications /drug therapy /economics /psychology; Treatment Outcome AccessionNumber 22010001000 Date bibliographic record published 17/11/2010 |
|
|
|